Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy.

Hepatology (Baltimore, Md.) - 1 Jul 2011

Hsu Chao-Wei, Yeh Chau-Ting

Abstract excerpt

UNLABELLED: With anti-hepatitis B virus (anti-HBV) therapy using peginterferon, the seroconversion of hepatitis B surface antigen (HBsAg), which is considered a cure of the disease, can be achieved in a small percentage of patients. Eight of 245 consecutive patients (3.27%) with chronic hepatitis B who received peginterferon therapy at our center achieved HBsAg seroclearance. Surprisingly, two of the eight...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Genes, Viral
Share to Hepatitis B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Source

Identifiers

PMID: 21503942
DOI: 10.1002/hep.24363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy.PMID 21503942Read ↗

Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen.Semantic proximity Read ↗

Successful interferon treatment in a patient chronically infected with hepatitis B virus carrying unusual S- (and P-) mutants in the presence of anti-HBs antibodies.Semantic proximity Read ↗

Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.Semantic proximity Read ↗

Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens.Semantic proximity Read ↗

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.Semantic proximity Read ↗

Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.Semantic proximity Read ↗

Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?Semantic proximity Read ↗

Hepatitis B virus S gene escape mutantsSemantic proximity Read ↗

Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.Semantic proximity Read ↗

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.Semantic proximity Read ↗

Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.Semantic proximity Read ↗

Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.